Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Van

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Cancers|February 24, 2024
Functional Homologous Recombination (HR) Screening Shows the Majority of <i>BRCA1/2</i>-Mutant Breast and Ovarian Cancer Cell Lines Are HR-ProficientTitia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen, et al.
Blood Advances|December 26, 2023
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformationStijn N R Fuchs, Ursula S A Stalmann, Inge A M Snoeren, et al.
Hemasphere|August 21, 2025
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALLRoger Mulet-Lazaro, Anikó Sijs-Szabó, Remco M Hoogenboezem, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Cancers|February 24, 2024
Functional Homologous Recombination (HR) Screening Shows the Majority of <i>BRCA1/2</i>-Mutant Breast and Ovarian Cancer Cell Lines Are HR-ProficientTitia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen, et al.
Blood Advances|December 26, 2023
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformationStijn N R Fuchs, Ursula S A Stalmann, Inge A M Snoeren, et al.
Hemasphere|August 21, 2025
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALLRoger Mulet-Lazaro, Anikó Sijs-Szabó, Remco M Hoogenboezem, et al.
Pageof 3